United States · FDA National Drug Code directory
Ondansetron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71205-713_35203011-d93c-4169-a9cb-90b6d20b146b
- Product NDC
- 71205-713
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Ondansetron
- Labeler
- Proficient Rx LP
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100412
- Source listing expiry
- 20261231
Source-listed ingredients
- ONDANSETRON — 8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 BAG (71205-713-10) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 71205-713-10
- 2 BLISTER PACK in 1 BAG (71205-713-20) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 71205-713-20
- 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71205-713-30) · 71205-713-30
- 60 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71205-713-60) · 71205-713-60
- 90 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71205-713-90) · 71205-713-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →